guest ::
Deciphering the cellular phase of AD using Single Cell Genomics
Note: Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details. Technical Summary The UK Dementia Research Institute (UK DRI) is an initiative funded by the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK. Funding details for UK DRI programmes will be added in 2019. Dr. Carlo Sala Frigerio will move together with the director to the UCL hub and take the full responsibility of the single cell core of the institute. His aim is to contribute to the full understanding of the cellular phase of Alzheimer’s disease (AD) and to identify critical pathways and cell biological responses that might help to develop novel therapeutic approaches for AD. He has extensive experience in genetics, biochemistry, molecular and cellular biology and genomics, as demonstrated by his publications. Since two years he has set up the single cell biology core in the laboratory of Bart De Strooper and several publications are in preparation. The move to UCL will allow to switch the focus of research towards human brain.
| Grant period | 2017-08-31 |
| Funding body | Medical Research Council |
| Grant number | grant.8538712 |
| Identifier | G:(Dimensions)grant.8538712 |
Recent Publications
There are no publications
Record created 2021-07-01, last modified 2021-09-24